In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy.

<h4>Aims</h4>The mdx mouse has proven to be useful in understanding the cardiomyopathy that frequently occurs in muscular dystrophy patients. Here we employed a comprehensive array of clinically relevant in vivo MRI techniques to identify early markers of cardiac dysfunction and follow d...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel J Stuckey, Carolyn A Carr, Patrizia Camelliti, Damian J Tyler, Kay E Davies, Kieran Clarke
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0028569&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850224749961019392
author Daniel J Stuckey
Carolyn A Carr
Patrizia Camelliti
Damian J Tyler
Kay E Davies
Kieran Clarke
author_facet Daniel J Stuckey
Carolyn A Carr
Patrizia Camelliti
Damian J Tyler
Kay E Davies
Kieran Clarke
author_sort Daniel J Stuckey
collection DOAJ
description <h4>Aims</h4>The mdx mouse has proven to be useful in understanding the cardiomyopathy that frequently occurs in muscular dystrophy patients. Here we employed a comprehensive array of clinically relevant in vivo MRI techniques to identify early markers of cardiac dysfunction and follow disease progression in the hearts of mdx mice.<h4>Methods and results</h4>Serial measurements of cardiac morphology and function were made in the same group of mdx mice and controls (housed in a non-SPF facility) using MRI at 1, 3, 6, 9 and 12 months after birth. Left ventricular (LV) and right ventricular (RV) systolic and diastolic function, response to dobutamine stress and myocardial fibrosis were assessed. RV dysfunction preceded LV dysfunction, with RV end systolic volumes increased and RV ejection fractions reduced at 3 months of age. LV ejection fractions were reduced at 12 months, compared with controls. An abnormal response to dobutamine stress was identified in the RV of mdx mice as early as 1 month. Late-gadolinium-enhanced MRI identified increased levels of myocardial fibrosis in 6, 9 and 12-month-old mdx mice, the extent of fibrosis correlating with the degree of cardiac remodeling and hypertrophy.<h4>Conclusions</h4>MRI could identify cardiac abnormalities in the RV of mdx mice as young as 1 month, and detected myocardial fibrosis at 6 months. We believe these to be the earliest MRI measurements of cardiac function reported for any mice, and the first use of late-gadolinium-enhancement in a mouse model of congenital cardiomyopathy. These techniques offer a sensitive and clinically relevant in vivo method for assessment of cardiomyopathy caused by muscular dystrophy and other diseases.
format Article
id doaj-art-5097eac8e4d040858df642d015ace3cb
institution OA Journals
issn 1932-6203
language English
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-5097eac8e4d040858df642d015ace3cb2025-08-20T02:05:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0171e2856910.1371/journal.pone.0028569In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy.Daniel J StuckeyCarolyn A CarrPatrizia CamellitiDamian J TylerKay E DaviesKieran Clarke<h4>Aims</h4>The mdx mouse has proven to be useful in understanding the cardiomyopathy that frequently occurs in muscular dystrophy patients. Here we employed a comprehensive array of clinically relevant in vivo MRI techniques to identify early markers of cardiac dysfunction and follow disease progression in the hearts of mdx mice.<h4>Methods and results</h4>Serial measurements of cardiac morphology and function were made in the same group of mdx mice and controls (housed in a non-SPF facility) using MRI at 1, 3, 6, 9 and 12 months after birth. Left ventricular (LV) and right ventricular (RV) systolic and diastolic function, response to dobutamine stress and myocardial fibrosis were assessed. RV dysfunction preceded LV dysfunction, with RV end systolic volumes increased and RV ejection fractions reduced at 3 months of age. LV ejection fractions were reduced at 12 months, compared with controls. An abnormal response to dobutamine stress was identified in the RV of mdx mice as early as 1 month. Late-gadolinium-enhanced MRI identified increased levels of myocardial fibrosis in 6, 9 and 12-month-old mdx mice, the extent of fibrosis correlating with the degree of cardiac remodeling and hypertrophy.<h4>Conclusions</h4>MRI could identify cardiac abnormalities in the RV of mdx mice as young as 1 month, and detected myocardial fibrosis at 6 months. We believe these to be the earliest MRI measurements of cardiac function reported for any mice, and the first use of late-gadolinium-enhancement in a mouse model of congenital cardiomyopathy. These techniques offer a sensitive and clinically relevant in vivo method for assessment of cardiomyopathy caused by muscular dystrophy and other diseases.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0028569&type=printable
spellingShingle Daniel J Stuckey
Carolyn A Carr
Patrizia Camelliti
Damian J Tyler
Kay E Davies
Kieran Clarke
In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy.
PLoS ONE
title In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy.
title_full In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy.
title_fullStr In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy.
title_full_unstemmed In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy.
title_short In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy.
title_sort in vivo mri characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0028569&type=printable
work_keys_str_mv AT danieljstuckey invivomricharacterizationofprogressivecardiacdysfunctioninthemdxmousemodelofmusculardystrophy
AT carolynacarr invivomricharacterizationofprogressivecardiacdysfunctioninthemdxmousemodelofmusculardystrophy
AT patriziacamelliti invivomricharacterizationofprogressivecardiacdysfunctioninthemdxmousemodelofmusculardystrophy
AT damianjtyler invivomricharacterizationofprogressivecardiacdysfunctioninthemdxmousemodelofmusculardystrophy
AT kayedavies invivomricharacterizationofprogressivecardiacdysfunctioninthemdxmousemodelofmusculardystrophy
AT kieranclarke invivomricharacterizationofprogressivecardiacdysfunctioninthemdxmousemodelofmusculardystrophy